Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma [CUT&RUN]

ABSTRACT: Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma [CUT&RUN]

PROVIDER: PRJNA1111557 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29025550_1.fastq.gz	Fastqsanger.gz
	SRR29025550_2.fastq.gz	Fastqsanger.gz
	SRR29025551_1.fastq.gz	Fastqsanger.gz
	SRR29025551_2.fastq.gz	Fastqsanger.gz
	SRR29025552_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma

Project description:Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma

| PRJNA1111545 | ENA

Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma [CUT&RUN]

Project description:Medulloblastoma is the most common malignant brain tumor of childhood. The highest-risk tumors are driven by recurrent Myc amplifications (Myc-MB) and experience poorer outcomes despite intensive multimodal therapy. The Myc transcription factor defines core regulatory circuitry for these tumors and acts to broadly amplify downstream pro-survival transcriptional programs. Therapeutic targeting of Myc directly has proven elusive, but inhibiting transcriptional cofactors may present an indirect means of drugging the oncogenic transcriptional circuitry sustaining Myc-MB. Independent CRISPR-Cas9 screens were pooled to identify conserved dependencies in Myc-MB. We performed chromatin conformation capture (Hi-C) from primary patient Myc-MB samples to map enhancer-promoter interactions. We then treated in vitro and xenograft models with the dual CDK9/7 inhibitor zotiraciclib to evaluate effect on Myc-driven programs and tumor growth. Eight CRISPR-Cas9 screens performed across three independent labs identify CDK9 as a conserved dependency in Myc-MB. Myc-MB cells are susceptible to CDK9 inhibition, which is synergistic with concurrent inhibition of CDK7. The dual CDK9/7 inhibitor zotiraciclib disrupts enhancer-promoter activity in Myc-MB and downregulates Myc-driven transcriptional programs, exerting potent anti-tumor effect.

2024-11-14 | GSE267470 | GEO

Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma [Hi-C]

Project description:Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma [Hi-C]

| PRJNA1111556 | ENA

Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma [RNA-seq]

Project description:Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma [RNA-seq]

| PRJNA1111558 | ENA

Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma [Hi-C]

2024-11-14 | GSE267471 | GEO

Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma [RNA-seq]

2024-11-14 | GSE267469 | GEO

Dual targeting of processive transcription for Myc-driven circuitry in medulloblastoma

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-11-14 | GSE267473 | GEO

Hijacking a neurodevelopmental epigenomic program in metastatic dissemination of medulloblastoma [Cut & Run]

Project description:Hijacking a neurodevelopmental epigenomic program in metastatic dissemination of medulloblastoma [Cut & Run]

| PRJNA799749 | ENA

Expression profiling of human medulloblastoma cell line ONS76 upon siRNA-mediated knockdown of KDM5A/LSD1

Project description:KDM5A/LSD1 is an important epigenetic regulator in medulloblastoma, the most frequent brain tumor of childhood. Here, the response of ONS76 medulloblastoma cells upon siRNA-mediated knockdown of KDM5A is analysed. The expression profile of ONS76 cells upon KDM5A knockdown was compared to mock control. Both conditions were run in triplicate.

2013-08-01 | E-GEOD-43552 | biostudies-arrayexpress

O-GlcNAcylation Promotes Cerebellum Development and Medulloblastoma Oncogenesis via SHH Signaling

Project description:Sonic hedgehog (Shh) signaling plays a critical role in regulating cerebellum development by maintaining the physiological proliferation of granule neuron precursors (GNPs), and its dysregulation leads to the oncogenesis of medulloblastoma. O-GlcNAcylation (O-GlcNAc) of proteins is an emerging regulator of brain function that maintains normal development and neuronal circuitry. Here, we demonstrate that O-GlcNAc transferase (OGT) in GNPs mediate the cerebellum development, and the progression of the Shh-subgroup of medulloblastoma. Specifically, OGT regulates the proliferation of GNPs by activating the Shh signaling pathway via O-GlcNAcylation at S355 of GLI family zinc finger 2 (Gli2), which in turn promotes its deacetylation and transcriptional activity via dissociation from p300, a histone acetyltransferases (HATs). Inhibition of OGT via genetic ablation or chemical inhibition improves survival in a medulloblastoma mouse model. These data uncover a critical role for O-GlcNAc signaling in cerebellar development, and pinpoint a potential therapeutic target for Shh-associated medulloblastoma.

2022-06-02 | PXD034270 |

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data